PEANUT ALLERGY
Clinical trials for PEANUT ALLERGY explained in plain language.
Never miss a new study
Get alerted when new PEANUT ALLERGY trials appear
Sign up with your email to follow new studies for PEANUT ALLERGY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Peanut allergy breakthrough? new drug combo aims to build lasting tolerance
Disease control Not yet recruitingThis study tests whether adding the drug tezepelumab to peanut oral immunotherapy (OIT) helps people with peanut allergy safely eat more peanut without symptoms. About 62 people aged 12 to 55 with severe peanut allergy will receive either tezepelumab or a placebo along with OIT f…
Matched conditions: PEANUT ALLERGY
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 26, 2026 11:13 UTC
-
Could 'Super-Heated' peanuts make allergy treatment safer?
Disease control Not yet recruitingThis study tests a new approach to peanut allergy treatment called oral immunotherapy (OIT), where people eat tiny, increasing amounts of peanut protein to build tolerance. It compares standard peanuts to 'autoclaved' peanuts (heated under high pressure to change their proteins) …
Matched conditions: PEANUT ALLERGY
Phase: PHASE2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 22, 2026 13:50 UTC